SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-007251
Filing Date
2023-03-10
Accepted
2023-03-10 16:24:43
Documents
12
Period of Report
2023-03-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 32093
  Complete submission text file 0001493152-23-007251.txt   204857

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sonn-20230310.xsd EX-101.SCH 3230
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sonn-20230310_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sonn-20230310_pre.xml EX-101.PRE 22361
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3616
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 23724013
SIC: 2834 Pharmaceutical Preparations